COVID BioResource

Working with committed and passionate researchers and participants, we are involved in coronavirus cutting edge research

At the emergence of the Coronavirus pandemic at the turn of 2020, our teams explored how we might contribute.

The COVID BioResource was the response by our network and our partners, using our unique expertise in sample handling and our participant contributions to drive research into the genetics of COVID.


We are recruiting two groups of people to the COVID BioResource.

  • those who have been diagnosed with COVID and have been admitted to hospital, both in the wards and in the Intensive Care Units (ICU). 
  • those who have been diagnosed with COVID but have mild symptoms or are asymptomatic (apparently no symptoms)

If you are a family member of one of the above we would also be interested in recruiting you whether you have had COVID or not.

There's a short video about human genetics and COVID on the GenOMICC site.

Want to make a difference?

If you join us, you are helping to speed the progress of medical research. Every one of us makes a difference

We are a key partner in the GenOMICC study - a major new human whole genome sequencing study taking place across the UK National Health Service.

Currently, the genomes of people (currently or previously in an intensive care unit with coronavirus and those who have mild or moderate symptoms) are being analysed.

The ultimate aim is to develop a full catalogue of human genetic variation and COVID by recruiting every single COVID-19 patient who admitted to intensive care in the UK.


If you are a researcher interested in COVID research see our section on Applying for NIHR BioResource support  and our COVID specific application form.